More importantly, blocking Musclin actions, either by genetic ablation or neutralizing antibody treatment, promotes energy expenditure and alleviates HFD induced-obesity and metabolic dysfunction. The gene discussed is OSTN; the disease is obesity due to melanocortin 4 receptor deficiency.